Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Alan Uretz, Phd, LAc
Alan Uretz's, Phd, LAc, areas of expertise include the fields of Traditional Chinese Medicine (TCM), Integrative Medicine, Academics and Pain Management. His clinical internships at Guangzhou University covered all branches of medicine including gerontology and pain management. Alan now serves as Dean of Chinese Medicine at the Midwest College of Oriental Medicine. He is also a Founding Director of CCAM Research Partners.